Xilio Therapeutics (XLO) P/E (2021 - 2026)
Xilio Therapeutics (XLO) P/E from Oct 22, 2021 to Jul 21, 2026. The TTM Xilio Therapeutics (XLO) P/E is -1.08. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Xilio Therapeutics (XLO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.08 | +20.46% |
| 2025 | -0.90 | +33.62% |
| 2024 | -0.67 | +261.33% |
| 2023 | -0.19 | -78.42% |
| 2022 | -0.86 | -66.93% |
| 2021 | -2.61 | N/A |
Comparison Xilio Therapeutics (XLO) P/E with competitors
Xilio Therapeutics (XLO) P/E is -1.08.